116 related articles for article (PubMed ID: 12270308)
1. Role of parathormone levels on T-cell response in hemodialysis patients.
Ozdemir FN; Yakupoglu U; Turan M; Arat Z; Karakayali H; Erdal R; Turan M
Transplant Proc; 2002 Sep; 34(6):2044-5. PubMed ID: 12270308
[No Abstract] [Full Text] [Related]
2. [The effect of parathormone on arterial blood pressure in patients on hemodialysis].
Kostić S; Veljković S; Cekić S; Nesić M; Cukuranović R; Koradjević G; Radenković S; Velicković D; Raicević R; Radenković M
Srp Arh Celok Lek; 1996; 124 Suppl 1():115-6. PubMed ID: 9102868
[TBL] [Abstract][Full Text] [Related]
3. [Effect of hemodialysis on levels of parathormone in blood of patients with chronic kidney failure].
Starzyk J; Kowalski D
Wiad Lek; 1993 Apr; 46(7-8):283-5. PubMed ID: 8249416
[TBL] [Abstract][Full Text] [Related]
4. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
Broulík P; Hrubý M
Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of terminal parathormone NH2 and COOH and plasma calcitonin in the blood of uremic patients under hemodialysis therapy].
Di Landro D; Zanatta GP; Simioni N; Pinzani A; Zotti D; Perin N; Bertoli M; Naso A; Ruffatti A; Gasparotto ML
Minerva Med; 1985 Mar; 76(9-10):419-23. PubMed ID: 3982699
[No Abstract] [Full Text] [Related]
6. Effect of intravenous alfacalcidol on lymphocyte phenotyping in hemodialysis patients.
Huraib S; Tanimu D; Abu-Romeh S; al-Khairy K; Quadri K; al-Ghamdi G; Iqbal A
Am J Kidney Dis; 1998 Dec; 32(6):1036-40. PubMed ID: 9856521
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone and T-cellular immunity in uremic patients in replacement dialytic therapy.
Angelini D; Carlini A; Giusti R; Grassi R; Mei E; Fiorini I; Mazzotta L; Antonelli A
Artif Organs; 1993 Feb; 17(2):73-5. PubMed ID: 8382471
[TBL] [Abstract][Full Text] [Related]
8. [Parathormone and peripheral neuropathy in patients on chronic hemodialysis].
Kostić SM; Djordjević V; Stefanović V
Srp Arh Celok Lek; 1985; 113(5-6):467-72. PubMed ID: 3003934
[No Abstract] [Full Text] [Related]
9. [Agonistic effect of calcitonin against parathormone in patients with chronic renal insufficiency on hemodialysis].
Rico Lenza H; Huertas García-Alejo R; del Rio Vázquez A; Espinos Pérez D
Rev Clin Esp; 1981 Sep; 162(6):271-4. PubMed ID: 7330322
[No Abstract] [Full Text] [Related]
10. [The discrepancy on measurement of parathyroid hormone in blood under the condition of diseases in hemodialysis patients with renal insufficiency and elderly osteoporotic patients].
Ueyoshi A; Kiura Y; Ota K; Okamoto Y
Ryumachi; 1988 Oct; 28(5):324-33. PubMed ID: 3227463
[No Abstract] [Full Text] [Related]
11. Immunomodulatory effects of secondary hyperparathyroidism on circulating CD4+ and CD8+ T-lymphocytes in chronic renal failure patients.
El Kelany MA; Maklad SS; El Fouhil DF; El Etreby EA; Saleh LH; El Sheikh NA
Egypt J Immunol; 2009; 16(2):71-82. PubMed ID: 22059355
[TBL] [Abstract][Full Text] [Related]
12. An increased serum level of parathyroid hormone is a risk factor for aortosclerosis in hemodialysis patients.
Kabaya T; Nitta K; Kimura H; Kawashima A; Mimuro T; Narusawa K; Nihei H
Nephron; 2000 Oct; 86(2):213-4. PubMed ID: 11015005
[No Abstract] [Full Text] [Related]
13. [Variations in serum levels of phosphorus (iP), calcium (Ca), calcitonin (iCT) and parathormone (iPTH) in patients under periodic hemodialysis. Effects of exogenous calcitonin therapy].
Bucciante G; Bernardi A; Biasia F; Milan G; Donato D
Minerva Med; 1985 Mar; 76(9-10):415-7. PubMed ID: 3982698
[No Abstract] [Full Text] [Related]
14. Anemia in patients on maintenance hemodialysis: the effect of parathyroid hormone.
Kostić S; Strahinjić S; Dordević V; Stefanović V
Acta Med Iugosl; 1986; 40(2):133-7. PubMed ID: 3728075
[No Abstract] [Full Text] [Related]
15. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of apolipoprotein A-I containing particles in chronic renal failure patients undergoing hemodialysis.
Cachera C; Kandoussi A; Equagoo K; Fruchart JC; Tacquet A
Am J Nephrol; 1990; 10(2):171-2. PubMed ID: 2112342
[No Abstract] [Full Text] [Related]
17. Effect of dialysate calcium concentration on plasma parathyroid hormone during hemodialysis.
McIntosh CH; Fuchs C; Dorn D; Quellhorst E; Henning HV; Hesch RD; Scheler F
Nephron; 1977; 19(2):88-94. PubMed ID: 887190
[TBL] [Abstract][Full Text] [Related]
18. Immune response in hemodialysis patients: is there any difference when low and high iPTH levels are compared?
Tzanno-Martins C; Futata E; Jorgetti V; Duarte AJ
Clin Nephrol; 2000 Jul; 54(1):22-9. PubMed ID: 10939753
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactive parathyroid hormone and serum insulin levels in patients on maintenance hemodialysis.
Stefanović V; Ivić M; Strahinjić S; Kostić S
Acta Med Iugosl; 1986; 40(4):275-84. PubMed ID: 3538787
[No Abstract] [Full Text] [Related]
20. Trend evaluation of aluminium in uraemic patients on chronic hemodialysis.
Di Iorio BR; Scarpino L; Bruno A; Confessore A; Gaudiano G; Altieri C; Smilari F; Papaleo D; Cosentino G; Terracciano V
Nephron; 1995; 71(4):471-2. PubMed ID: 8587634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
